Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EG 626

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
7-Ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626) (0.3-3 mg/kg i.v.), a new cyclic AMP phosphodiesterase… Expand
Is this relevant?
1980
1980
Effects of Phthalazinol (EG 626), a cyclic AMP phosphodiesterase inhibitor, a thromboxane A2 antagonist and an… Expand
Is this relevant?
1980
1980
To enhance the biostability of the ester linkage of 7-ethoxycarbonyl-4-hydroxymethyl-1(2H)-phthalazinone, which has potent… Expand
Is this relevant?
1979
1979
Abstract Effects of phthalazinol, EG 626, on the membrane and mechanical properties of the vascular smooth muscles, namely… Expand
Is this relevant?
1979
1979
Phthalazinol (EG 626), a thromboxane A2 antagonist and cyclic AMP phosphodiesterase inhibitor, has been shown to prevent the… Expand
Is this relevant?
1977
1977
Sticking and aggregation of platelets to the damaged or denuded endothelial surface of atheromatous plaque are common findings in… Expand
Is this relevant?